第一单位：
Zentalis Pharmaceuticals, Inc., San Diego, CA, USA.
作者：
Daehwan,Kim [1]
;
Heekyung,Chung [1]
;
Wen,Liu [1]
;
Kangjin,Jeong [2]
;
Tugba Y,Ozmen [2]
;
Furkan,Ozmen [2]
;
Matthew J,Rames [3]
;
Sangyub,Kim [1]
;
Xiao,Guo [1]
;
Nathan,Jameson [1]
;
Petrus R,de Jong [1]
;
Steven,Yea [1]
;
Laurie,Harford [1]
;
Jiali,Li [1]
;
Cara A,Mathews [4]
;
Deborah B,Doroshow [5]
;
Vincent J,Charles [6]
;
Doris,Kim [1]
;
Kimberlee,Fischer [1]
;
Ahmed A,Samatar [1]
;
Adrian,Jubb [1]
;
Kevin D,Bunker [1]
;
Kimberly,Blackwell [1]
;
Fiona,Simpkins [7]
;
Funda,Meric-Bernstam [8]
;
Gordon B,Mills [2]
;
Olivier,Harismendy [1]
;
Jianhui,Ma [9]
;
Mark R,Lackner [10]
作者单位：
Zentalis Pharmaceuticals, Inc., San Diego, CA, USA.
[1]
Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
[2]
Division of Oncological Sciences, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.;Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
[3]
Program in Women's Oncology, Women & Infants Hospital, Legorreta Cancer Center of Alpert Medical School at Brown University, Providence, RI, USA.
[4]
Early Phase Trials Unit, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
[5]
The University of Chicago Medicine & Biological Sciences, Chicago, IL, USA.
[6]
Ovarian Cancer Research Center, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
[7]
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[8]
Zentalis Pharmaceuticals, Inc., San Diego, CA, USA. jma@zentalis.com.
[9]
Zentalis Pharmaceuticals, Inc., San Diego, CA, USA. mlackner@zentalis.com.
[10]
DOI
10.1038/s41698-024-00787-4
PMID
39755818
发布时间
2025-01-07
换一批
